-
-
-
-
-
-
-
Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $28 at BofA Securities
-
-
-
-
-
-
-
Harmony Biosciences shows seizure reduction in dravet syndrome trial
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY)
-
-
-
-
-
-
-
Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $50 at Cantor Fitzgerald
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY)
-
-
-
-
-
-
-
Oppenheimer Assumes Harmony Biosciences Holdings Inc. (HRMY) at Outperform
-
-
-
-
-
-
-
Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald
-
416,802 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

